Using pay for performance to improve treatment implementation for adolescent substance use disorders: Results from a cluster randomized trial

Archives of Pediatrics and Adolescent Medicine

Volumn 166, Issue 10, 2012, Pages 938-944

  Garner, Bryan R ^a   Godley, Susan H ^a   Dennis, Michael L ^a   Hunter, Brooke D ^a   Bair, Christin M L ^a   Godley, Mark D ^a  

^a CHESTNUT HEALTH SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; FUNDING; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL FEE; OUTCOME ASSESSMENT; PAY FOR PERFORMANCE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; CLINICAL COMPETENCE; COMMUNITY MENTAL HEALTH SERVICES; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPENSITY SCORE; REIMBURSEMENT, INCENTIVE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84867118386     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2012.802     Document Type: Article

References (43)

1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
2. Dudley RA. Pay-for-performance research: how to learn what clinicians and policy makers need to know. JAMA. 2005;294(14):1821-1823. (Pubitemid 41434629)
3. Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. JAMA. 2005;294(14):1788-1793. (Pubitemid 41434625)
4. Doran T, Fullwood C, Gravelle H, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355(4):375-384. (Pubitemid 44127540)
5. Garner BR, Godley SH, Bair CML. The impact of pay-for-performance on therapists' intentions to deliver high-quality treatment. J Subst Abuse Treat. 2011; 41(1):97-103.
6. McLellan AT, Kemp J, Brooks A, Carise D. Improving public addiction treatment through performance contracting: the Delaware experiment. Health Policy. 2008; 87(3):296-308.
7. Nahra TA, Reiter KL, Hirth RA, Shermer JE, Wheeler JRC. Cost-effectiveness of hospital pay-for-performance incentives. Med Care Res Rev. 2006;63(1)(suppl):49S-72S. (Pubitemid 43947900)
8. Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S. Does pay-for-performance improve the quality of health care? Ann Intern Med. 2006;145 (4):265-272. (Pubitemid 46768610)
9. Rosenthal MB, Frank RG. What is the empirical basis for paying for quality in health care? Med Care Res Rev. 2006;63(2):135-157. (Pubitemid 43344149)
10. Rosenthal MB, Landon BE, Normand SL, Frank RG, Epstein AM. Pay for performance in commercial HMOs. N Engl J Med. 2006;355(18):1895-1902. (Pubitemid 44664647)
11. Shepard DS, Calabro JAB, Love CT, McKay JR, Tetreault J, Yeom HS. Counselor incentives to improve client retention in an outpatient substance abuse aftercare program. Adm Policy Ment Health. 2006;33(6):629-635. (Pubitemid 44726824)
12. Campbell S, Reeves D, Kontopantelis E, Middleton E, Sibbald B, Roland M. Quality of primary care in England with the introduction of pay for performance. N Engl J Med. 2007;357(2):181-190.
13. Epstein AM. Pay for performance at the tipping point. N Engl J Med. 2007;356(5): 515-517. (Pubitemid 46193082)
14. Glickman SW, Ou FS, DeLong ER, et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA. 2007;297(21):2373-2380. (Pubitemid 46883750)
15. Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356(5):486-496. (Pubitemid 46193076)
16. Rosenthal MB, Dudley RA. Pay-for-performance: will the latest payment trend improve care? JAMA. 2007;297(7):740-744. (Pubitemid 46294563)
17. An LC, Bluhm JH, Foldes SS, et al. A randomized trial of a pay-for-performance program targeting clinician referral to a state tobacco quitline. Arch Intern Med. 2008;168(18):1993-1999.
18. Bremer RW, Scholle SH, Keyser D, Houtsinger JVK, Pincus HA. Pay for performance in behavioral health. Psychiatr Serv. 2008;59(12):1419-1429.
19. Campbell SM, Reeves D, Kontopantelis E, Sibbald B, Roland M. Effects of pay for performance on the quality of primary care in England. N Engl J Med. 2009; 361(4):368-378.
20. Greene SE, Nash DB. Pay for performance: an overview of the literature. Am J Med Qual. 2009;24(2):140-163.
21. Emmert M, Eijkenaar F, Kemter H, Esslinger AS, Schöffski O. Economic evaluation of pay-for-performance in health care: a systematic review [published online June 10 2011]. Eur J Health Econ. doi:10.1007/s10198-011-0329- 8. 21660562.
22. Scott A, Sivey P, Ait Ouakrim D, et al The effect of financial incentives on the quality of health care provided by primary care physicians. Cochran Database Syst Rev. 2011;(9):CD008451. http: //onlinelibrary .wiley.com/doi /10 .1002/14651858 .CD008451.pub2/abstract;jsessionid= 80CA53339EF0B599C69F8796E06C1458 .d01t02. Accessed May 31, 2012.
23. Vandrey R, Stitzer ML, Acquavita SP, Quinn-Stabile P. Pay-for-performance in a community substance abuse clinic. J Subst Abuse Treat. 2011;41(2):193-200.
24. Institute of Medicine. Rewarding Provider Performance: Aligning Incentives in Medicare. Washington, DC: National Academy Press; 2007.
25. Institute of Medicine. Bridging the Gap Between Practice and Research: Forging Partnerships With Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press; 1998.
26. Fixsen DL, Naoom SF, Blasé KA, Friedman RM, Wallace F. Implementation Research: A Synthesis of the Literature. Tampa, FL: National Implementation Research Network; 2005.
27. Rohrbach LA, Grana R, Sussman S, Valente TW. Type II translation: transporting prevention interventions from research to real-world settings. Eval Health Prof. 2006;29(3):302-333. (Pubitemid 44131398)
28. Garner BR. Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review. J Subst Abuse Treat. 2009;36 (4):376-399.
29. Garner BR, Godley SH, Dennis ML, Godley MD, Shepard DS. The Reinforcing Therapist Performance (RTP) experiment: study protocol for a cluster randomized trial. Implement Sci. 2010;5:5 http://www.ncbi.nlm.nih.gov/pmc/articles /PMC2824685/?tool=pubmed. Accessed May 27, 2012.
30. National Center on Addiction and Substance Abuse (CASA) at Columbia University. Adolescent Substance Use: America's #1 Public Health Problem. New York, NY: CASA; 2011.
31. Dennis ML, Godley SH, Diamond G, et al. The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials. J Subst Abuse Treat. 2004; 27(3):197-213. (Pubitemid 40292028)
32. Godley MD, Godley SH, Dennis ML, Funk RR, Passetti LL. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction. 2007;102(1):81-93. (Pubitemid 46006474)
33. Godley SH, Garner BR, Passetti LL, Funk RR, Dennis ML, Godley MD. Adolescent outpatient treatment and continuing care: main findings from a randomized clinical trial. Drug Alcohol Depend. 2010;110(1-2):44-54.
34. Godley SH, Garner BR, Smith JE, Meyers RJ, Godley MD. A large-scale dissemination and implementation model for evidence-based treatment and continuing care. Clin Psychol (New York). 2011;18(1):67-83.
35. Garner BR, Godley SH, Funk RR, Dennis ML, Smith JE, Godley MD. Exposure to Adolescent Community Reinforcement Approach treatment procedures as amediator of the relationship between adolescent substance abuse treatment retention and outcome. J Subst Abuse Treat. 2009;36(3):252-264.
36. Smith JE, Lundy SL, Gianini L. Community Reinforcement Approach (CRA) and Adolescent Community Reinforcement Approach (A-CRA) Coding Manual. Albuquerque: University of New Mexico; 2007.
37. Bucklin BR, Dickinson AM. Individual monetary incentives: a review of different types of arrangements between performance and pay. J Organ Behav Manag. 2001;21(3):45-137. (Pubitemid 33715359)
38. Dennis ML, Titus JC, White M, Unsicker J, Hodgkins D. Global Appraisal of Individual Needs (GAIN): Administration Guide for the GAIN and Related Measures. Bloomington, IL: Chestnut Health Systems; 2003.
39. Charpentier PA. Urn Randomization Program gRand [computer program]. Version 1.10. New Haven, CT: Yale University; 2003.
40. Giraudeau B, Ravaud P. Preventing bias in cluster randomised trials. PLoS Med. 2009;6(5):e1000065 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668175 /?tool=pubmed. Accessed May 27, 2012.
41. Raudenbush SW, Bryk AS, Congdon R. HLM 6 for Windows [computer program]. Lincolnwood, IL: Scientific Software International Inc; 2004.
42. Bedard PL, Krzyzanowska MK, Pintilie M, Tannock IF. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings. J Clin Oncol. 2007;25(23):3482-3487. (Pubitemid 47310887)
43. Donnellan MB, Oswald FL, Baird BM, Lucas RE. The mini-IPIP scales: tiny-yeteffective measures of the Big Five factors of personality. Psychol Assess. 2006; 18(2):192-203. (Pubitemid 44106660)